Warts are noncancerous growths on the skin or mucous\nmembranes caused by the human papillomavirus (HPV). <\/p>\n\n\n\n
Salicylic acid is the only FDA approved active ingredient at\nconcentrations between 5% and 40% subject to the delivery base like plaster\/collodion-like\nor karaya gum, glycol plaster vehicle.<\/p>\n\n\n\n
Since wart removers are considered as OTC drugs, the manufacturers must comply with all drug requirements such as establishment registration<\/a>, drug listings<\/a>, cGMP requirements and labeling. <\/p>\n\n\n\n In the labeling, they must include \u201cWart remover<\/a>\u201d along\nwith the established name of the drug.<\/p>\n\n\n\n The labels must carry the indications of use, direction of\nuse, warnings and contact phone numbers to call. <\/p>\n\n\n\n Liberty Management Group<\/a> provides assistance with drug establishment registration<\/a>, drug listing<\/a> and label review<\/a> and US agent service to foreign drug companies.<\/p>\n\n\n\n Sudha S<\/p>\n\n\n\n Regulatory Consultant<\/p>\n\n\n\n Email : office@libertymanagement.us<\/p>\n\n\n\n http:\/\/www.fdahelp.us<\/a><\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" Warts are noncancerous growths on the skin or mucous membranes caused by the human papillomavirus (HPV). Salicylic acid is the only FDA approved active ingredient at concentrations between 5% and 40% subject to the delivery base like plaster\/collodion-like or karaya gum, glycol plaster vehicle. Since wart removers are considered as OTC drugs, the manufacturers must … Continue reading “WART REMOVER REGULATION”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[42,40],"class_list":["post-297","post","type-post","status-publish","format-standard","hentry","category-fda-registration-drug","tag-fda-drug-registration","tag-fda-drug-registration-renewal"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=297"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/297\/revisions"}],"predecessor-version":[{"id":298,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/297\/revisions\/298"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}